Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.
Cancer Control
; 24(5): 1073274817729076, 2017.
Article
in En
| MEDLINE
| ID: mdl-28975822
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Neuroendocrine Tumors
Type of study:
Guideline
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Control
Journal subject:
NEOPLASIAS
Year:
2017
Type:
Article
Affiliation country:
United States